ArticleBiologics : targets & therapy2021

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab.

Timothy Fitzgerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.